Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Alexandra S. Nikitina"'
Autor:
Kavya Ramkumar, Vladimir N. Yarovenko, Alexandra S. Nikitina, Igor V. Zavarzin, Mikhail M. Krayushkin, Leonid V. Kovalenko, Adrian Esqueda, Srinivas Odde, Nouri Neamati
Publikováno v:
Molecules, Vol 15, Iss 6, Pp 3958-3992 (2010)
Raltegravir was the first HIV-1 integrase inhibitor that gained FDA approval for use in the treatment of HIV-1 infection. Because of the emergence of IN inhibitor-resistant viral strains, there is a need to identify innovative second-generation IN in
Externí odkaz:
https://doaj.org/article/23cb1d8e6e93474580135bba273d1aab
Autor:
Igor V. Zavarzin, L. V. Kovalenko, Nouri Neamati, Adrian Esqueda, Alexandra S. Nikitina, Srinivas Odde, Mikhail M. Krayushkin, Kavya Ramkumar, Vladimir N. Yarovenko
Publikováno v:
Molecules; Volume 15; Issue 6; Pages: 3958-3992
Molecules
Molecules, Vol 15, Iss 6, Pp 3958-3992 (2010)
Molecules
Molecules, Vol 15, Iss 6, Pp 3958-3992 (2010)
Raltegravir was the first HIV-1 integrase inhibitor that gained FDA approval for use in the treatment of HIV-1 infection. Because of the emergence of IN inhibitor-resistant viral strains, there is a need to identify innovative second-generation IN in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45855112258bfc2135e6a13a81312d0